Literature DB >> 23783104

The Endocrine Society guidelines: when the confidence cart goes before the evidence horse.

Juan P Brito1, Juan P Domecq, Mohammed H Murad, Gordon H Guyatt, Victor M Montori.   

Abstract

CONTEXT: In 2005, the Endocrine Society (TES) adopted the GRADE system of developing clinical practice guidelines. Grading of Recommendations, Assessment, Development, and Evaluation working group guidance suggests that strong recommendations based on low or very low (L/VL) confidence may often be inappropriate, and has offered a taxonomy of paradigmatic situations in which strong recommendations based on L/VL confidence estimates may be appropriate.
OBJECTIVE: We sought to characterize strong recommendations of TES based on L/VL confidence evidence. DATA SOURCES AND EXTRACTION: We identified all strong recommendations based on L/VL confidence evidence published in TES guidelines between 2005 and 2011. We identified those consistent with one of the paradigmatic situations in the taxonomy. DATA SYNTHESIS: Two hundred six of 357 (58%) of the recommendations of TES were strong; of these, 121 (59%) were based on L/VL confidence evidence. Of these 121, 35 (29%) were consistent with one of the paradigmatic situations. The most common situation (13, 11%) was of a strong recommendation against the intervention because of low confidence evidence for benefit and high confidence evidence for harm. The remaining 86 (71%) comprised 43 (36%) "best practice" statements for which sensible alternatives do not exist; 5 (4%) in which recommendations were for "additional research"; 5 (4%) in which greater confidence in the estimates was warranted; and 33 (27%) for which we could not find a compelling explanation for the incongruence.
CONCLUSIONS: Guideline panels should beware of formulating strong recommendations when confidence in estimates is low. Our taxonomy when such recommendations are appropriate may be helpful.

Entities:  

Mesh:

Year:  2013        PMID: 23783104     DOI: 10.1210/jc.2013-1814

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Can we trust strong recommendations based on low quality evidence?

Authors:  Liang Yao; Gordon H Guyatt; Benjamin Djulbegovic
Journal:  BMJ       Date:  2021-11-25

2.  Methodological quality and synthesis of case series and case reports.

Authors:  Mohammad Hassan Murad; Shahnaz Sultan; Samir Haffar; Fateh Bazerbachi
Journal:  BMJ Evid Based Med       Date:  2018-02-02

3.  Trustworthiness of randomized trials in endocrinology-A systematic survey.

Authors:  José Gerardo González-González; Edgar Gerardo Dorsey-Treviño; Neri Alvarez-Villalobos; Francisco Jesús Barrera-Flores; Alejandro Díaz González-Colmenero; Carolina Quintanilla-Sánchez; Victor M Montori; Rene Rodriguez-Gutierrez
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

4.  A systematic breakdown of the levels of evidence supporting the European Society of Cardiology guidelines.

Authors:  Wouter B van Dijk; Diederick E Grobbee; Martine C de Vries; Rolf H H Groenwold; Rieke van der Graaf; Ewoud Schuit
Journal:  Eur J Prev Cardiol       Date:  2019-08-14       Impact factor: 7.804

5.  Development of a Patient Decision Aid on the Choice of Diabetes Medication for Filipino Patients with Type 2 Diabetes Mellitus.

Authors:  Anna Angelica Macalalad-Josue; Lia Aileen Palileo-Villanueva; Mark Anthony Sandoval; Jose Paolo Panuda
Journal:  J ASEAN Fed Endocr Soc       Date:  2019-04-04

6.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Authors:  Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

7.  Are American follow-up recommendations in endocrinology actionable? A systematic review of clinical practice guidelines.

Authors:  Francisco J Barrera; Karina Raygoza-Cortez; Mariana García-Leal; Juan P Brito; Naykky M Singh Ospina; René Rodríguez-Gutiérrez
Journal:  Endocrine       Date:  2021-01-21       Impact factor: 3.633

8.  American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Authors:  M R DeBaun; L C Jordan; A A King; J Schatz; E Vichinsky; C K Fox; R C McKinstry; P Telfer; M A Kraut; L Daraz; F J Kirkham; M H Murad
Journal:  Blood Adv       Date:  2020-04-28

9.  Is the endocrine research pipeline broken? A systematic evaluation of the Endocrine Society clinical practice guidelines and trial registration.

Authors:  Naykky Singh Ospina; Rene Rodriguez-Gutierrez; Juan P Brito; William F Young; Victor M Montori
Journal:  BMC Med       Date:  2015-08-12       Impact factor: 8.775

10.  UpToDate adherence to GRADE criteria for strong recommendations: an analytical survey.

Authors:  Thomas Agoritsas; Arnaud Merglen; Anja Fog Heen; Annette Kristiansen; Ignacio Neumann; Juan P Brito; Romina Brignardello-Petersen; Paul E Alexander; David M Rind; Per O Vandvik; Gordon H Guyatt
Journal:  BMJ Open       Date:  2017-11-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.